Brief: Adaptive Biotechnologies Q2 EPS USD -0.33
02/08/2023 21:06
Aug 02 (Reuters) - Adaptive Biotechnologies Q2 revenue USD 48.926 million vs. IBES estimate USD 44.9 million. * Q2 operating expenses USD 96.744 million * Q2 operating income USD -47.818 million * Q2 net income USD -47.811 million * Q2 adjusted EBITDA USD -24.8 million * Outlook FY Revenue USD 205-215 Million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile